Previous reports have shown upregulation of GLO1 in various cancers including melanoma [21], breast cancer [22,23,24], prostate cancer [25,26], gastric cancer [27,28], pancreatic cancer [29] and renal carcinoma (clear cell carcinoma) [30]. This evidence concerns the gene GLO1 and prostate cancer.